Full Text View
Tabular View
Study Results
Related Studies
A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)
This study has been terminated.
( Strategic business decision not to pursue indication due to lack of demonstrable medical need )
Study NCT00836498   Information provided by Merck

First Received on February 3, 2009.   Last Updated on February 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rotavirus
Interventions listed in this trial
Comparator: RotaTeq
Comparator: Placebo
Comparator: RotaTeq + Placebo
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services